NASDAQ : SLBT
SL Science Holding Limited — Key statistics
Healthcare · Biotechnology · Taiwan
Last price 1.17 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 667.21M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 684.32M |
| Enterprise Value | 681.25M |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 26, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 566.59M |
| Shares Outstanding | 570.27M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.15% |
| Float | n/a |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 209.27 |
| Forward PS | n/a |
| PB Ratio | 0.93 |
| P/TBV Ratio | 144.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 208.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 4.90 |
| Quick Ratio | 3.84 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -138.93% |
| Return on Capital Employed (ROCE) | -47.33% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $218,007 |
| Profits Per Employee | -$157,959 |
| Employee Count | 15 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 105,167 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | n/a |
| 52-Week Price Change | -88.45% |
| 50-Day Moving Average | 1.89 |
| 200-Day Moving Average | 6.14 |
| Relative Strength Index (RSI) | 29.26 |
| Average Volume (20 Days) | 47,978 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 36,588 |
| Short Previous Month | 51,477 |
| Short % of Shares Out | 0.01% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.47 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 3.27M |
| Gross Profit | 1.26M |
| Operating Income | -2.31M |
| Pretax Income | -2.26M |
| Net Income | -2.37M |
| EBITDA | -2.28M |
| EBIT | -2.31M |
| Loss Per Share | -$0.64 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 3.37M |
| Total Debt | 305,669 |
| Net Cash | 3.07M |
| Net Cash Per Share | $0.01 |
| Equity (Book Value) | 4.73M |
| Book Value Per Share | 1.29 |
| Working Capital | 3.55M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -2.95M |
| Capital Expenditures | -325,646 |
| Depreciation & Amortization | 25,468 |
| Net Borrowing | n/a |
| Free Cash Flow | -3.28M |
| FCF Per Share | -$0.01 |
Margins
| Measure | Value |
|---|
| Gross Margin | 38.41% |
| Operating Margin | -70.65% |
| Pretax Margin | -69.24% |
| Profit Margin | -72.46% |
| EBITDA Margin | -69.87% |
| EBIT Margin | -70.65% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -53.73% |
| FCF Yield | -0.48% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 48.75 |
| Piotroski F-Score | n/a |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |